# Facilitators and Barriers to Eptinezumab Administration in Thailand

> **NCT07035197** · — · COMPLETED · sponsor: **Chulalongkorn University** · enrollment: 30 (actual)

## Conditions studied

- Migraine
- Treatment
- Treatment Refusal

## Interventions

- **DRUG:** Eptinezumab
- **OTHER:** Sham (No Treatment)

## Key facts

- **NCT ID:** NCT07035197
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-25
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07035197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07035197, "Facilitators and Barriers to Eptinezumab Administration in Thailand". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07035197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*